IWD 2024: Eight women taking the lead in drug discovery


For International Women’s Day (IWD), Diana Spencer highlights DDW interviews with eight inspirational women leaders in drug discovery and development.

  1. Stefanie Dedeurwaerdere, UCB

Stefanie Dedeurwaerdere

Stefanie Dedeurwaerdere is Global Strategy Lead for Pipeline Development in Global Epilepsy & Rare Syndromes at UCB. In her day-to-day role, she is responsible for the development of UCB’s epilepsy discovery strategy, working with researchers to advance understanding of epilepsies while ensuring candidates for a future clinical treatment pipeline to improve the lives of those living with the condition.

Read the interview.

  1. Dr Blythe Sather, Tune Therapeutics

Dr Blythe SatherDr Blythe Sather is VP and Head of Research at Tune Therapeutics. Prior to Tune, Sather was Senior Director of T Cell Engineering at Lyell Immunopharma, and an Associate Director of Research at Juno Therapeutics. She also led the research collaboration with Editas Medicine. She has a PhD in Immunology from the University of Washington, and did postdoctoral work at Seattle Children’s Research Institute.

Read the interview.

  1. Kathryn Golden, bit.bio

Kathryn GoldenKathryn Golden is SVP Technical Operations and Manufacturing at bit.bio. She has a track record of shepherding complex drug candidates from discovery to pivotal trials. Her expertise includes integrated process development, phase-appropriate quality and regulatory coordination, and management of contract manufacturing organisations.

Read the interview.

  1. Tracy M Woody, Cessation Therapeutics

Tracy M WoodyTracy M Woody, President & Chief Executive Officer, Cessation Therapeutics, has over 25 years of commercial experience in pharmaceuticals, biologics, and medical devices, across a range of therapeutic areas in diverse markets. She has previously served as a board member of Esperion Therapeutics since May 2019, and currently serves as a board member of Shorla Oncology.

Read the interview.

  1. Catherine Emond, Novartis

Catherine Emond is the Head of Immunology and Neuroscience at Novartis UK. She is responsible for driving long-term strategies that can help change the lives of people with challenging immunological and neurological conditions. With over two decades of leadership experience, Emond is known for her broad brand lifecycle management achievements and for always maintaining a patient centric focus.

Read the interview.

  1. Katie Abouzahr, Janssen

Katie AbouzahrKatie Abouzahr is the Vice President, Autoantibody Portfolio and Maternal Fetal Disease Area Leader at the Janssen Pharmaceutical Companies of Johnson & Johnson. She speaks with Megan Thomas about the future for Janssen’s investigational medicine nipocalimab and antibody therapeutics at large.

Read the interview.

  1. Adele Hannigan, Antibody Analytics

Adele HanniganDr Adele Hannigan is Chief Business Officer of Antibody Analytics. Her transition from chemistry to biology was sparked by a desire to understand the data the pharmacologists fed back to her during her time as a synthetic medicinal chemist. This inspired her to change direction, first by investigating the role of Epstein-Barr Virus in epithelial cancers during her PhD, and subsequently TGFβ-signalling in breast cancer during her post-doctoral career.

Read the interview.

  1. Monika Paule, Caszyme

Monika PauleMonika Paule is CEO and Co-founder of Caszyme, a biotech company in Vilnius, Lithuania, which aims to deliver novel gene editing solutions. Paule is also a Board member of the Lithuanian Biotechnology Association and Initiator & Facilitator of Lithuania’s networking group Women in Biotech.

Read the interview.

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free